Axa Has Trimmed Its Dexcom INC (DXCM) Position by $37.31 Million

October 13, 2018 - By Vivian Park

DexCom, Inc. (NASDAQ:DXCM) LogoInvestors sentiment increased to 1.22 in Q2 2018. Its up 0.07, from 1.15 in 2018Q1. It is positive, as 21 investors sold DXCM shares while 82 reduced holdings. 46 funds opened positions while 80 raised stakes. 88.54 million shares or 9.89% less from 98.26 million shares in 2018Q1 were reported. Marco Inv Mngmt Ltd Liability Com holds 0.04% in DexCom, Inc. (NASDAQ:DXCM) or 3,000 shares. Vanguard Gp holds 0.03% of its portfolio in DexCom, Inc. (NASDAQ:DXCM) for 7.13M shares. State Board Of Administration Of Florida Retirement holds 0.03% of its portfolio in DexCom, Inc. (NASDAQ:DXCM) for 120,747 shares. Clinton Group Inc Inc reported 2,117 shares. 4,823 were accumulated by Gam Ag. Huntington Bankshares invested 0% in DexCom, Inc. (NASDAQ:DXCM). Great West Life Assurance Can holds 9,800 shares or 0% of its portfolio. Moreover, Qs Invsts Lc has 0% invested in DexCom, Inc. (NASDAQ:DXCM). Hanseatic Mgmt Svcs reported 0.02% stake. Missouri-based Atwood And Palmer has invested 0.01% in DexCom, Inc. (NASDAQ:DXCM). Pillar Pacific Mgmt Ltd owns 0.05% invested in DexCom, Inc. (NASDAQ:DXCM) for 5,000 shares. Quantbot Technology LP holds 22,909 shares or 0.15% of its portfolio. Bkd Wealth Lc has 0.04% invested in DexCom, Inc. (NASDAQ:DXCM). Asset Mngmt One holds 8,210 shares or 0% of its portfolio. Synovus Fincl has invested 0% of its portfolio in DexCom, Inc. (NASDAQ:DXCM).

Since April 16, 2018, it had 0 buys, and 37 sales for $42.35 million activity. Pacelli Steven Robert had sold 3,114 shares worth $317,335. 10,330 shares valued at $1.48 million were sold by MOY JEFFREY on Monday, September 10. Another trade for 10,000 shares valued at $858,974 was made by GREGG TERRANCE H on Tuesday, May 15. Another trade for 25,495 shares valued at $3.66M was made by SAYER KEVIN R on Monday, September 10. 5,000 shares were sold by Balo Andrew K, worth $497,816. Another trade for 20,577 shares valued at $2.85 million was sold by Leach Jacob Steven.

Axa decreased its stake in Dexcom Inc (DXCM) by 20.48% based on its latest 2018Q2 regulatory filing with the SEC. Axa sold 396,928 shares as the company’s stock rose 47.99% with the market. The institutional investor held 1.54M shares of the health care company at the end of 2018Q2, valued at $146.38 million, down from 1.94M at the end of the previous reported quarter. Axa who had been investing in Dexcom Inc for a number of months, seems to be less bullish one the $11.23 billion market cap company. The stock increased 3.82% or $4.67 during the last trading session, reaching $127.07. About 1.08M shares traded. DexCom, Inc. (NASDAQ:DXCM) has risen 98.67% since October 13, 2017 and is uptrending. It has outperformed by 83.05% the S&P500.

Axa, which manages about $26.09B US Long portfolio, upped its stake in Newfield Expl Co (NYSE:NFX) by 432,265 shares to 1.09M shares, valued at $32.98 million in 2018Q2, according to the filing. It also increased its holding in Cimarex Energy Co (NYSE:XEC) by 47,328 shares in the quarter, for a total of 49,741 shares, and has risen its stake in Intel Corp (Prn).

Analysts await DexCom, Inc. (NASDAQ:DXCM) to report earnings on November, 7. They expect $-0.10 EPS, down 233.33 % or $0.07 from last year’s $-0.03 per share. After $-0.10 actual EPS reported by DexCom, Inc. for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

More news for DexCom, Inc. (NASDAQ:DXCM) were recently published by:, which released: “Tandem’s t:slim X2 insulin pump OK’d in Canada” on October 13, 2018.‘s article titled: “Strange: Bullish DXCM Analysts Actually See -2.12% Downside” and published on September 17, 2018 is yet another important article.

DexCom, Inc. (NASDAQ:DXCM) Ratings Coverage

Among 11 analysts covering DexCom (NASDAQ:DXCM), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. DexCom had 19 analyst reports since May 3, 2018 according to SRatingsIntel. Berenberg upgraded the shares of DXCM in report on Monday, August 6 to “Buy” rating. The firm earned “Buy” rating on Friday, June 8 by J.P. Morgan. The firm earned “Outperform” rating on Monday, July 2 by Raymond James. The rating was maintained by Morgan Stanley on Thursday, October 11 with “Equal-Weight”. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Overweight” rating by Stephens on Thursday, August 23. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Buy” rating by Canaccord Genuity on Thursday, August 23. The stock of DexCom, Inc. (NASDAQ:DXCM) has “Market Perform” rating given on Wednesday, September 12 by Northland Capital. The rating was upgraded by JP Morgan to “Overweight” on Friday, June 8. Canaccord Genuity maintained DexCom, Inc. (NASDAQ:DXCM) on Thursday, August 2 with “Buy” rating. Canaccord Genuity maintained the stock with “Buy” rating in Thursday, May 3 report.

DexCom, Inc. (NASDAQ:DXCM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News